Quantcast
Last updated on April 18, 2014 at 11:16 EDT

Latest Nephrology Stories

2013-10-02 14:03:08

University of Michigan researchers developed, validated novel risk score to predict new onset end-stage renal disease End-stage renal disease is one of the major public health problems among solid organ transplant recipients that is associated with death after transplant and high cost of care. Using the national data of 43,514 liver transplant recipients, researchers at University of Michigan researchers in collaboration with Arbor Research Collaborative for Health created and validated...

2013-10-02 12:29:51

BETHLEHEM, Pa., Oct. 2, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) announced today that it has entered into an exclusive distributor agreement with Lauer's Medical Water Purification to sell the Aquaboss(®) in-center water treatment systems in the U.S. The distribution relationship of the Lauer Aquaboss system is not new to B.Braun. Currently, B. Braun's affiliates have sold and distributed Lauer water treatment systems in various countries all over the world. Lauer is an...

2013-10-01 12:29:39

Surveyed Nephrologists State that 25 Percent of CKD-ND Patients are Likely Candidates for Recently Approved Injectafer, According to a New Report from BioTrends Research Group EXTON, Pa., Oct. 1, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, among surveyed nephrologists, familiarity with Roche's Mircera, is low, but is still second highest among six late-stage renal therapies...

2013-09-30 23:38:32

Dr. Mohan's significant gift will help fund the USC/UKRO Kidney Research Center, which will conduct basic and applied research programs to identify the causes, improve upon the existing treatments, and—ultimately—seek a cure for all forms of kidney disease. Los Angeles, CA (PRWEB) September 30, 2013 UKRO (University Kidney Research Organization), a Los Angeles–based nonprofit charity supporting kidney disease research, is extremely pleased to announce a generous contribution of...

2013-09-30 23:32:40

Filing of GranuFlo lawsuits is on the rise as the GranuFlo recall alleges serious side effect risk associated with GranuFlo use Los Angeles, CA (PRWEB) September 30, 2013 The GranuFlo recall lawyers at Baron and Budd are reviewing GranuFlo claims relating to the March 2012 GranuFlo and NaturaLyte recall. A dialysis concentrate used during dialysis to help clean the blood, both GranuFlo and NaturaLyte are manufactured and marketed by Fresenius Medical Care, the world's largest provider...

2013-09-26 16:26:06

AUSTIN, Texas, Sept. 26, 2013 /PRNewswire/ -- Preliminary data presented last week at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual scientific meeting demonstrated that TVA Medical's FLEX System can create vascular access for hemodialysis patients without traditional open surgery. The technology is being studied outside of the United States and is currently not available in the U.S. The Company intends to seek Food and Drug Administration...

2013-09-26 08:28:02

SAN DIEGO, Sept. 26, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that the Defense Advanced Research Projects Agency (DARPA) has exercised an option agreement to proceed with year-three of a five-year $6.8 million contract that was awarded to Aethlon on September 30, 2011 under DARPA's Dialysis-Like Therapeutics...

2013-09-23 23:33:12

As litigation involving allegations of life-threatening heart problems continues to move forward Resource4thePeople’s national network of attorneys will continue to offer complimentary consultations to consumers responding to FDA's concerns about dialysis patients suffering heart irregularities. San Diego, CA (PRWEB) September 23, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/Dialysis-Lawsuit.html Resource4thePeople today announced its latest consumer update...

2013-09-23 08:28:33

Automated online tool helps physicians to prescribe hemodialysis treatment plans designed to fit patients' lifestyles LAWRENCE, Mass., Sept. 23, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the immediate availability of the NxStage Dosing Calculator. Designed for use with the NxStage(®) System One(TM), this online tool helps physicians develop prescriptions tailored to patients' clinical and...

2013-09-20 23:02:15

The Firm is investigating GranuFlo recall lawsuits on behalf of dialysis patients who suffered heart attacks, strokes, and other life-threatening heart problems within 72 hours of a dialysis treatment with GranuFlo or NaturaLyte dialysis concentrates. New York, New York (PRWEB) September 20, 2013 Hundreds of GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) filed on behalf of patients who allegedly suffered serious heart problems related to the 2012 recall of GranuFlo and NaturaLyte...


Latest Nephrology Reference Libraries

Hypertension (journal)
2012-05-14 11:48:30

Hypertension is a peer-reviewed scientific journal established in 1979 and published monthly by the American Heart Association (AHA). As of May 2012, the editor-in-chief is John E. Hall (University of Mississippi). Publishing formats include original manuscripts, invited review summaries, invited case-based reviews, recent study highlights, invited brief commentaries, scientific or technical tutorials, letter to the editor, and novel findings of unusual interest. This journal focuses on...

More Articles (1 articles) »